Leukemia

Showing NaN - NaN of 95

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

Completed
  • Leukemia
  • Scottsdale, Arizona
  • +209 more
Dec 14, 2022

Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

Completed
  • Leukemia
  • arsenic trioxide
  • +4 more
  • Roseville, California
  • +191 more
Dec 14, 2022

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
Nov 29, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

    Completed
    • Drug/Agent Toxicity by Tissue/Organ
    • Leukemia
    • Boston, Massachusetts
    • +9 more
    Nov 9, 2022

    Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia

    Active, not recruiting
    • Leukemia
    • DNA analysis
    • +3 more
    • San Diego, California
    • +160 more
    Aug 2, 2022

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

    Active, not recruiting
    • Leukemia
    • Birmingham, Alabama
    • +184 more
    Feb 4, 2022

    Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)

    Active, not recruiting
    • Leukemia
    • Birmingham, Alabama
    • +175 more
    Aug 16, 2021

    Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

    Completed
    • Leukemia
    • Birmingham, Alabama
    • +197 more
    Mar 22, 2021

    Leukemia Trial in Israel, United States (biological, drug, procedure)

    Completed
    • Leukemia
    • sargramostim
    • +7 more
    • Birmingham, Alabama
    • +98 more
    Oct 23, 2020

    Leukemia Trial in United States (rituximab, cyclophosphamide, pentostatin)

    Completed
    • Leukemia
    • rituximab
    • +3 more
    • Scottsdale, Arizona
    • +142 more
    Nov 9, 2020

    Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)

    Terminated
    • Leukemia
    • rituximab
    • fludarabine phosphate
    • Anniston, Alabama
    • +386 more
    Apr 9, 2020

    Leukemia Trial in Canada, United States (biological, drug, other, procedure)

    Completed
    • Leukemia
    • anti-thymocyte globulin
    • +10 more
    • Birmingham, Alabama
    • +51 more
    Apr 7, 2020

    Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

    Terminated
    • Leukemia
    • Lymphoma
    • therapeutic allogeneic lymphocytes
    • +8 more
    • Denver, Colorado
    • +22 more
    Apr 8, 2020

    Leukemia Trial in Scottsdale, Rochester (Alemtuzumab, Rituximab, Sargramostim)

    Completed
    • Leukemia
    • Alemtuzumab
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    Mar 30, 2020

    Leukemia, Lymphoma Trial in Scottsdale, Jacksonville, Rochester (Rituximab, Cyclophosphamide, Lenalidomide)

    Completed
    • Leukemia
    • Lymphoma
    • Rituximab
    • +3 more
    • Scottsdale, Arizona
    • +2 more
    Jan 7, 2020

    Leukemia Trial in Iowa City, Baltimore, Rochester (tipifarnib)

    Completed
    • Leukemia
    • Iowa City, Iowa
    • +2 more
    Nov 5, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • +4 more
    • therapeutic allogeneic lymphocytes
    • +6 more
    • Denver, Colorado
    • +13 more
    Sep 13, 2019

    Leukemia, Lymphoma, HIV Trial in United States (Fludarabine and Busulfan, Fludarabine and Melphalan, Busulfan and Fludarabine)

    Completed
    • Leukemia
    • +2 more
    • Fludarabine and Busulfan
    • +3 more
    • Phoenix, Arizona
    • +10 more
    Dec 6, 2018

    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic

    Completed
    • Leukemia
    • +2 more
    • Allogeneic bone marrow transplantation
    • Peripheral blood stem cell transplantation
    • Birmingham, Alabama
    • +44 more
    Oct 24, 2017